Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan;8(1):23.
doi: 10.1007/s13205-017-1035-8. Epub 2017 Dec 18.

Microencapsulation of reuterin to enhance long-term efficacy against food-borne pathogen Listeria monocytogenes

Affiliations

Microencapsulation of reuterin to enhance long-term efficacy against food-borne pathogen Listeria monocytogenes

Santosh Kumar Mishra et al. 3 Biotech. 2018 Jan.

Abstract

The aim of this study was to microencapsulate the reuterin produced by Lactobacillus reuteri BPL-36 strain for its long-term efficacy against food-borne pathogen Listeria monocytogenes. Lactobacillus reuteri BPL-36 strain previously isolated from a human infant fecal sample in lab was selected for the present study based on its ability to produce reuterin. The organism displayed a broad-spectrum antimicrobial activity. Reuterin concentration of 89.63 mM was obtained in the MRS-glycerol medium after 16 h incubation at 37 °C. The reuterin concentration required to inhibit the growth of Pseudomonas aeruginosa, Escherichia coli O157: H7, Salmonella typhi, Staphylococcus aureus, and Listeria monocytogenes was found to be 1.0, 2.0, 2.0, 4.0, and 10.0 AU/mL, respectively. Microencapsulation of reuterin to enhance long-term efficacy against food-borne pathogens was done. Results in this study indicated that the release characteristics of reuterin from the encapsulated particles were pH dependent. The release characteristics were unaffected by the storage of encapsulated reuterin at 4 °C for 2 weeks. The anti-listerial efficacy of the encapsulated reuterin was tested against L. monocytogenes in the BHI medium adjusted to pH 5.0 with a reuterin content equivalent to 16 mM, similar to un-encapsulated (free) reuterin. Encapsulated reuterin demonstrated enhanced efficacy against L. monocytogenes for longer duration of time when compared with un-encapsulated (free) reuterin. The present work demonstrated a novel antimicrobial delivery system that ensured much better capability of inhibiting the growth of L. monocytogenes throughout 24 h incubation at 37 °C.

Keywords: Lactobacillus reuteri; Microencapsulation; Pathogens; Reuterin; Safety.

PubMed Disclaimer

Conflict of interest statement

Compliance with ethical standardsThis article does not contain any studies with human or animal subjects.Additional informed consents were obtained from all the parents of infants from whom fecal samples were collected for isolation of lactic acid bacteria.Santosh Kumar Mishra, R. K. Malik, Harsh Panwar, and Amit Kumar Barui declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Colorimetric quantification of reuterin produced by L. reuteri BPL-36 at different time intervals after incubation at 37 °C. Data points are means of triplicate readings with SEMs represented by vertical bars
Fig. 2
Fig. 2
Morphology of microcapsules at 10× magnification
Fig. 3
Fig. 3
pH-dependent release pattern of encapsulated reuterin during storage at 37 °C. Data points are means of triplicate OD620 readings with SEMs represented by vertical bars
Fig. 4
Fig. 4
pH-dependent release pattern of encapsulated reuterin during storage at 4 °C. Data points are means of triplicate OD620 readings with SEMs represented by vertical bars
Fig. 5
Fig. 5
Log counts (CFU/mL, mean ± SD) of pathogens Listeria monocytogenes in BHI medium without or with free reuterin, encapsulated reuterin during incubation at 37 °C (reuterin 16 mM)

Similar articles

Cited by

References

    1. Axelsson LT, Chung TC, Dobrogosz WJ, Lindgren SE. Production of a broad spectrum antimicrobial substance by Lactobacillus reuteri. Microb Ecol Health Dis. 1989;2:131–136. doi: 10.3109/08910608909140210. - DOI
    1. Bieble H, Mengel K, Zeng AP, Deckwer WD. Microbial production of I, 3-propanediol. Appl Microbiol Biotechnol. 1999;52:289–297. doi: 10.1007/s002530051523. - DOI - PubMed
    1. Cao-Hoang L, Chaine A, Gregoire L, Wache Y. Potential of nisin-incorporated sodium caseinate films to control Listeria in artificially contaminated cheese. Food Microbiol. 2010;27(7):940–944. doi: 10.1016/j.fm.2010.05.025. - DOI - PubMed
    1. Chi-Zhang Y, Yam KL, Chikindas ML. Effective control of Listeria monocytogenes by combination of nisin formulated and slowly released into a broth system. Int J Food Microbiol. 2004;90:15–22. doi: 10.1016/S0168-1605(03)00168-5. - DOI - PubMed
    1. Chung TC, Axelsson L, Lindgren SE, Dobrogosz WJ. In vitro studies on reuterin synthesis by Lactobacillus reuteri. Microb Eco Health Dis. 1989;2(2):137–144.

LinkOut - more resources